These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6226490)

  • 1. Systemic side-effects of three topical steroids in diseased skin.
    Salde L; Lassus A
    Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
    Schmidt H; Hjorth N; Salde L
    J Int Med Res; 1981; 9(3):236-8. PubMed ID: 7016629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
    Turnbull BC
    Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
    [No Abstract]   [Full Text] [Related]  

  • 4. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC
    J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the base on the results of clinical trials with topical corticosteroids.
    Vollum DI; Sparkes CG
    Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of budesonide and betamethasone- 17,21-dipropionate in psoriasis.
    Fredriksson T; Salde L
    Curr Med Res Opin; 1982; 8(3):171-7. PubMed ID: 6751704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 9. Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.
    de la Brassine M; Kint A; Lachapelle JM; Tennstedt D
    J Int Med Res; 1984; 12(5):307-9. PubMed ID: 6238861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and experimental studies on blood histamine levels in topical corticosteroid therapy].
    Tanaka K
    Nihon Hifuka Gakkai Zasshi; 1987 Feb; 97(2):125-36. PubMed ID: 2955146
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic uses of halcinonide.
    Beveridge GW
    Scott Med J; 1977 Jul; 22(3):231-3. PubMed ID: 329412
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
    Mensing H; Korsukewitz G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis.
    Kostarelos K; Teknetzis A; Lefaki I; Ioannides D; Minas A
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):5-9. PubMed ID: 10877245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
    Shimao S
    J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 0.1% halcinonide with 0.05% betamethasone dipropionate in the treatment of acute and chronic dermatoses.
    Levy A
    Curr Med Res Opin; 1977-1978; 5(4):328-32. PubMed ID: 343993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
    Shupack JL; Jondreau L; Kenny C; Stiller MJ
    Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.